The DOI matches its Crossref record; 33 of the 35 references it cites were found in a registry or an index.
Prevalence, Treatment, and Control of Diagnosed Diabetes in the U.S. National Health and Nutrition Examination Survey 1999–2004
Abstract
Purpose This study aimed to examine the trends in prevalence, treatment, and control of diagnosed diabetes in United States adults 20 years of age or older.Methods Data from the National Health and Nutrition Examination Survey 1999-2004 were used. Glycemic, blood pressure, and total cholesterol target levels were defined as having glycosylated hemoglobin <7.0%, blood pressure <130/80 mm Hg, and total cholesterol <200 mg/dL, respectively.Results The prevalence of diagnosed diabetes was 7.8% in 2003-2004 and increased significantly in people aged 40-59 years, women, non-Hispanic whites, and obese people in the period 1999-2004. Although there was no significant change in the pattern of antidiabetic treatment, the age-adjusted percentage of people with diagnosed diabetes achieving glycemic and blood pressure target levels increased from 35.8% to 57.1% (p = 0.002) and from 35.7% to 48.3% (p = 0.04), respectively. However, there were only insignificant increases in percentages of those persons achieving total cholesterol target level (from 48.8% to 50.4%) and those achieving all 3 target levels (from 7.5% to 13.2%).Conclusions In 1999-2004, the prevalence of diagnosed diabetes increased significantly in some subgroups of the population. However, the increases in percentages of people with diabetes achieving glycemic and blood pressure targets are encouraging, although there is room for improvement.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In particular many racial/ethnic minority groups (particularly Blacks/African-Americans and Hispanics-Latinos) are at greater risk of obesity, heart disease, diabetes, and cardiovascular events (204, 206, 207).”
From Sleep: important considerations for the prevention of cardiovascular disease (2016) · cites this paper as [207]
In the citing paper
“African-Americans and Mexican-Americans are at greater risk of developing diabetes compared to non-Hispanic whites [3]”
From Association between sleep deficiency and cardiometabolic disease: implications for health disparities (2016) · cites this paper as [3]
In the citing paper
“Unfortunately, racial/ethnic and socioeconomic disparities in these diseases exist such that minority populations, such as African Americans and Hispanics, and those of lower socioeconomic status, experience a greater burden.”
From Association between sleep deficiency and cardiometabolic disease: implications for health disparities (2016) · cites this paper as [3]
Citations
Cites
1 retracted
Thiazolidinediones for the treatment of type 2 diabetes
Elte, J. W. F., & Blickle, J. (2007) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2006.09.007 · Cited by 77
RetractedGrundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Chobanian, A. V. (2003) · JAMA · doi:10.1001/jama.289.19.2560 · Cited by 25,386
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Chobanian, A. V., Bakris, G. L., Black, H. R., Cushman, W. C., Green, L. A., Izzo, J. L., Jones, D. W., Materson, B. J., Oparil, S., Wright, J. T., et al. (2003) · Hypertension · doi:10.1161/01.hyp.0000107251.49515.c2 · Cited by 13,271
Haffner, S. M., Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807233390404 · Cited by 7,000
Stearne, M. R., Palmer, S. L., Hammersley, M. S., Franklin, S. L., Spivey, R. S., Lévy, J., Tidy, C. R., Bell, N. J., Steemson, J., Barrow, B. A., et al. (1998) · UCL Discovery (University College London) · Cited by 4,803
Economic Costs of Diabetes in the U.S. in 2002
American Diabetes Association (2003) · Diabetes Care · doi:10.2337/diacare.26.3.917 · Cited by 4,147
Flagged first, then by citations
2 of the 35 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- Klein, 2001, Age adjustment using the 2000 projected US population, Healthy People 2010 Stat Notes, 20, 1
- American Diabetes Association, 2001, Standards of medical care for patients with diabetes mellitus, Diabetes Care, 24, S33, 10.2337/diacare.24.11.1988 · DOI
Cited by
Sorted by citations
Items 101–200 of 231
Aguilar, R. B. (2011) · Clinical Therapeutics · doi:10.1016/j.clinthera.2011.04.008 · Cited by 31
Yang, J., Zhang, B., Wang, E., Xia, S., & Chen, Y. (2021) · BMC Ophthalmology · doi:10.1186/s12886-021-01933-3 · Cited by 30
Ipragliflozin: A novel sodium-glucose cotransporter 2 inhibitor developed in Japan
Ohkura, T. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i1.136 · Cited by 29
Beyond Glycemic Control: Treating the Entire Type 2 Diabetes Disorder
Brunton, S. (2009) · Postgraduate Medicine · doi:10.3810/pgm.2009.09.2054 · Cited by 29
US Trends in Glycemic Control, Treatment, and Comorbidity Burden in Patients With Diabetes
Shaya, F. T., Yan, X., Lin, P., Simoni‐Wastila, L., Bron, M., Baran, R., & Donner, T. W. (2010) · The Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2010.00365.x · Cited by 29
Pharmacology, efficacy and safety of liraglutide in the management of type 2 diabetes
Campbell, R. K., & Neumiller, J. J. (2010) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s7314 · Cited by 29
Prevalence of diabetic retinopathy in patients with recently diagnosed diabetes mellitus
Lee, K. M. C., & Sum, W. M. R. (2011) · Clinical and Experimental Optometry · doi:10.1111/j.1444-0938.2010.00574.x · Cited by 29
Health Care Disparities and Diabetes Care: Practical Considerations for Primary Care Providers
White, R. O., Beech, B. M., & Miller, S. T. (2009) · Clinical Diabetes · doi:10.2337/diaclin.27.3.105 · Cited by 29
Long-Term Engagement with Health-Management Technology: a Dynamic Process in Diabetes.
Klasnja, P., Kendall, L., Pratt, W., & Blondon, K. (2015) · PubMed · Cited by 30
Tentolouris, N., Andrianakos, A., Karanikolas, G., Karamitsos, D., Trontzas, P., Krachtis, P., Christoyannis, F., Tavaniotou, E., Nikolia, Z., Kaskani, E., et al. (2012) · HORMONES · doi:10.14310/horm.2002.1378 · Cited by 28
Lyra, R., Silva, R. D. S., Montenegro, R. M., Matos, M. V. C., Cézar, N. J. B., & Maurício-da-Silva, L. (2010) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302010000600009 · Cited by 26
Cho, J., Choi, Y., Kim, H., Lee, J., & Yoon, K. (2011) · Journal of Telemedicine and Telecare · doi:10.1258/jtt.2011.101006 · Cited by 25
Blood Pressure Control in Diabetes
Cummings, D. M., Doherty, L., Howard, G., Howard, V. J., Safford, M. M., Prince, V., D, B. M. K. M., & Lackland, D. T. (2010) · Diabetes Care · doi:10.2337/dc09-1824 · Cited by 25
Social-Ecological Factors of Leisure-Time Physical Activity in Black Adults
Li, K., Seo, D., Torabi, M., Peng, C. J., Kay, N. S., & Kolbe, L. J. (2012) · American Journal of Health Behavior · doi:10.5993/ajhb.36.6.7 · Cited by 24
Treatment of type 2 diabetes with saxagliptin: a pharmacoeconomic evaluation in Argentina
Elgart, J. F., Caporale, J., González, L., Aiello, E., Waschbusch, M., & Gagliardino, J. J. (2013) · Health Economics Review · doi:10.1186/2191-1991-3-11 · Cited by 25
Fonseca, V. A. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.03.016 · Cited by 23
Giorgino, F., Caruso, I., & Napoli, R. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108478 · Cited by 24
Disability and its correlates with chronic morbidities among U.S. adults aged 50−<65 years
Zhao, G., Ford, E. S., Li, C., Crews, J. E., & Mokdad, A. H. (2008) · Preventive Medicine · doi:10.1016/j.ypmed.2008.11.002 · Cited by 23
Long work hours is associated with suboptimal glycemic control among US workers with diabetes
Davila, E. P., Florez, H. J., Trepka, M. J., Fleming, L. E., Niyonsenga, T., Lee, D. J., & Parkash, J. (2011) · American Journal of Industrial Medicine · doi:10.1002/ajim.20923 · Cited by 25
New Perspectives in Type 2 Diabetes, Cardiovascular Risk, and Treatment Goals
Wysham, C. (2010) · Postgraduate Medicine · doi:10.3810/pgm.2010.05.2142 · Cited by 21
Ikeda, N., Nishi, N., Noda, H., & Noda, M. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.03.011 · Cited by 22
Meloni, A. R., DeYoung, M. B., Han, J., Best, J. H., & Grimm, M. F. (2013) · Cardiovascular Diabetology · doi:10.1186/1475-2840-12-48 · Cited by 20
Wong, H. K., Ong, K. L., Cheung, C., & Cheung, B. M. Y. (2014) · Annals of Epidemiology · doi:10.1016/j.annepidem.2014.05.001 · Cited by 22
Sazlina, S., Mastura, I., Ahmad, Z., Cheong, A. T., Bujang, M. A., Haniff, J., Lee, P. Y., Alwi, S. A. R. S., Chew, B., & SriWahyu, T. (2013) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.12070 · Cited by 21
Marino, A. B., & Cole, S. W. (2014) · Journal of Pharmacy Practice · doi:10.1177/0897190014522063 · Cited by 22
Ghabban, S. J., Althobaiti, B., Farouk, I., Al Hablany, M., Ghabban, A., Alghbban, R., Harbi, S., & Albalawi, A. E. (2020) · Cureus · doi:10.7759/cureus.11683 · Cited by 20
Unmet Primary Care Needs in Diabetic Patients with Multimorbidity in a Medically Underserved Area
Jackson, B. M., Gutierrez, M. L., Relyea, G. E., Carlton, E. L., Ahn, S., Binkley, B. L., & Bailey, J. E. (2017) · Health Services Research and Managerial Epidemiology · doi:10.1177/2333392817702760 · Cited by 19
Harjo, T. C., Pérez, A., López, V. A. Q., & Wong, N. D. (2010) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2010.0043 · Cited by 18
Xu, F., Ware, R. S., Tse, L. A., Wang, Y.-F., Wang, Z., Hong, X., Chan, E. Y. Y., Dunstan, D. W., & Owen, N. G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088719 · Cited by 19
Role of angiotensin receptor blockers in diabetes: implications of recent clinical trials
McFarlane, S. I. (2009) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.09.115 · Cited by 18
Shah, B. M., Mezzio, D. J., Ho, J., & Ip, E. J. (2015) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2015.04.009 · Cited by 18
Calle, M. C., Vega‐López, S., Segura‐Pérez, S., Volek, J. S., & Pérez‐Escamilla, R. (2010) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000109 · Cited by 17
Liu, X., & Song, P. (2013) · American Journal of Hypertension · doi:10.1093/ajh/hpt109 · Cited by 17
Haltmeier, T., Benjamin, E., Beale, E., Inaba, K., & Δημητριάδης, Δ. (2016) · World Journal of Surgery · doi:10.1007/s00268-016-3469-2 · Cited by 17
van Pul, K. M., Kruidenier, L. M., Nicolaï, S. P., de Bie, R. A., Nieman, F. H. M., Prins, M. H., & Teijink, J. A. W. (2012) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2012.04.008 · Cited by 16
Review of studies on the effect of bile acid sequestrants in patients with type 2 diabetes mellitus
Levy, P. (2010) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2010.0087 · Cited by 15
Alawadi, F., Abdelgadir, E., Bashier, A. M., Hassanein, M. M., Rashid, F., Alsaeed, M., Hafidh, K., Elsayed, M. A., Abuelkheir, S., & Farooqi, M. H. (2019) · Oman Medical Journal · doi:10.5001/omj.2019.04 · Cited by 15
Brissette, C., Jenkins, A. L., Choleva, L., & Vuksan, V. V. V. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.08.183 · Cited by 17
Janghorbani, M., Papi, B., & Amini, M. (2015) · Journal of Diabetes Investigation · doi:10.1111/jdi.12349 · Cited by 14
Epidemiology of Ocular Functions and Diseases in Persons With Diabetes
Klein, R., & Klein, R. (2018) · Europe PMC (PubMed Central) · Cited by 13
Chou, H.-Y., Truitt, K. E., Moberly, J. B., Merante, D., Choi, Y. E., Mun, Y., & Pfützner, A. (2012) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2012.01631.x · Cited by 13
Liu, X., Zhu, T., Manojlovich, M., Cohen, H. W., & Tsilimingras, D. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182807 · Cited by 13
Tom, S. E., Brown, J., Avilés-Santa, L. M., Sotres‐Alvarez, D., Castañeda, S. F., Patel, S. R., Perreira, K. M., Sánchez-Johnsen, L., Shah, N. A., Zee, P. C., et al. (2019) · Sleep Health · doi:10.1016/j.sleh.2019.10.001 · Cited by 14
Cheng, H., Lu, T., Wang, J., Xia, Y., Chai, X., Zhang, M., Yao, Y., Zhou, N., Zhou, S., Chen, X., et al. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00201 · Cited by 13
Hypertension as part of the metabolic syndrome
Cheung, B. M. Y. (2008) · Journal of Human Hypertension · doi:10.1038/jhh.2008.63 · Cited by 13
The Role of Colesevelam Hydrochloride in Hypercholesterolemia and Type 2 Diabetes Mellitus
Brunetti, L., & DeSantis, E. R. H. (2010) · Annals of Pharmacotherapy · doi:10.1345/aph.1m728 · Cited by 13
Qaddoumi, M. G., Al-Khamis, Y., Channanath, A. M., Tuomilehto, J., & Badawi, D. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00412 · Cited by 12
Implications of incretin-based therapies on cardiovascular disease
Rotz, M. E., Ganetsky, V. S., Sen, S., & Thomas, T. F. (2014) · International Journal of Clinical Practice · doi:10.1111/ijcp.12572 · Cited by 13
Sodium-Glucose Cotransporter 2 Inhibitors in the Treatment of Type 2 Diabetes Mellitus
Vivian, E. (2015) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721715607643 · Cited by 13
Shin, J.-Y., Shim, H.-Y., & Jun, J. K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110412 · Cited by 11
Is the Prevalence of Visual Impairment Rising or Falling in the People With Diabetes Mellitus?
Klein, R., & Klein, R. (2013) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2013.4023 · Cited by 11
Sleep Quality among Type 2 Saudi Diabetics.
IJAR, Alshenghiti., D. A., Alsadran., D. F., Alzahrani., D. R., & Assiri., D. I. M. (2017) · International Journal of Advanced Research · doi:10.21474/ijar01/3070 · Cited by 11
Xu, S., Sun, F., Xu, W., Jiao, K., Shi, B., Xie, X., Wang, Y., Zhu, M., & Ji, Q. (2016) · Nigerian Journal of Clinical Practice · doi:10.4103/1119-3077.181359 · Cited by 11
Doubova, S. V., Lamadrid‐Figueroa, H., & Pérez‐Cuevas, R. (2013) · Journal of Hypertension · doi:10.1097/hjh.0b013e3283613090 · Cited by 10
Patient tolerance and acceptance of colesevelam hydrochloride: focus on type-2 diabetes mellitus.
Brunetti, L., & DeSantis, E. R. H. (2015) · PubMed Central · Cited by 10
The Epidemiology of Diabetic Retinopathy
Klein, R., & Klein, R. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4557-0737-9.00045-x · Cited by 10
Clinical Experience with Continuous Glucose Monitoring in Adults
Fabiato, K., Buse, J. B., Duclos, M., Largay, J. F., Izlar, C., O'Connell, T., Stallings, J. E., & Dungan, K. M. (2009) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2009.0004 · Cited by 10
Managing cardiovascular risk factors: Trial evidence in women
Hsia, J. A. (2010) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2010.01.010 · Cited by 9
Fasting Versus Postprandial Hyperglycemia as a Treatment Target to Lower Elevated Hemoglobin A1C
Shaefer, C. F., Reid, T., Vlajnic, A., Zhou, R., & DIGENIO, A. G. (2015) · Endocrine Practice · doi:10.4158/ep14498.or · Cited by 9
Effects of a Community-Based Pilot Intervention on Home Food Availability among U.S. Households
Cassinat, R., Bruening, M. M., Crespo, N. C., Gutiérrez, M., Chavez, A., Ray, F., & Vega‐López, S. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17228327 · Cited by 10
Diabetes Mellitus and Erectile Dysfunction
Nikolaidou, B., Nouris, C., Lazaridis, A. A., Sampanis, C., & Doumas, M. N. (2014) · Springer eBooks · doi:10.1007/978-3-319-08272-1_12 · Cited by 9
Osuji, C. U., Nzerem, B. A., Dioka, C. E., Meludu, S., & Onwubuya, E. I. (2012) · Journal of Diabetes Mellitus · doi:10.4236/jdm.2012.23050 · Cited by 9
The effect of group clinics in the control of diabetes
Desouza, C. V., Rentschler, L. M., & Haynatzki, G. R. (2010) · Primary care diabetes · doi:10.1016/j.pcd.2010.09.004 · Cited by 9
Clinical overview of saxagliptin for Type 2 diabetes management
Rosenstock, J. (2010) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.10.60 · Cited by 9
Townsend, R. R., Forker, A. D., Bhosekar, V., Yadao, A. M., & Keefe, D. L. (2011) · Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2011.00552.x · Cited by 8
Chako, K. Z., Phillipo, H., Mafuratidze, E., & Zhou, D. T. (2014) · Chinese Journal of Biology · doi:10.1155/2014/672980 · Cited by 8
Bays, H. (2012) · Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy · doi:10.2147/dmso.s32018 · Cited by 6
Patient considerations in the management of type 2 diabetes – critical appraisal of dapagliflozin
Brooks, A. D., Salvo, M. C., & Thacker, S. M. (2014) · Patient Preference and Adherence · doi:10.2147/ppa.s59169 · Cited by 7
Schwalm, J.-D., McCready, T., Lear, S. A., Lamelas, P. M., Garis, L., Musa, H., Vincent, K., Islam, S., Attaran, A., McKee, M., et al. (2020) · CJC Open · doi:10.1016/j.cjco.2020.10.006 · Cited by 7
Trends of diabetes in Beijing, China
Ma, A., Lyu, J., Dong, Z., Nie, L., Xie, C., Jiang, B., Han, X., Dong, J., Zhao, Y., & Li, L. (2024) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003207 · Cited by 6
Kok, A., Hariram, A., Webb, D., & Amod, A. (2021) · Journal of Endocrinology Metabolism and Diabetes of South Africa · doi:10.1080/16089677.2021.1897227 · Cited by 6
Strict glycemic control and mortality risk among US adults with type 2 diabetes
Davila, E. P., Florez, H. J., Trepka, M. J., Fleming, L. E., Niyonsenga, T., Lee, D. J., & Parkash, J. (2011) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2011.03.004 · Cited by 6
Clinical utility of fixed combinations of sitagliptin–metformin in treatment of type 2 diabetes
Green, J., Karen, K., & Cox, M. E. (2010) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmsott.s10195 · Cited by 7
Lederer, S., Ruggiero, L., Sisen, N. M., LePain, N., O’Connor, K. G., Wang, Y., Chen, J., Lash, J. P., & Fischer, M. J. (2018) · BMC Nephrology · doi:10.1186/s12882-018-1079-y · Cited by 5
Vega‐López, S., Calle, M. C., Fernández, M. L., Kollannoor-Samuel, G., Chhabra, J., Todd, M. W., Segura‐Pérez, S., D'Agostino, D. C., Damio, G., & Pérez‐Escamilla, R. (2013) · Journal of Health Care for the Poor and Underserved · doi:10.1353/hpu.2013.0171 · Cited by 5
Abdelgadir, E., Alsaeed, M., Hafidh, K., Bashier, A. M., Rashid, F., Altayb, F., Sayyah, F., Farooqi, M. H., & Alawadi, F. (2019) · Oman Medical Journal · doi:10.5001/omj.2019.58 · Cited by 5
Ways To Reduce Cardiovascular Disease in Diabetes
Garg, S. K., DiDomenico, D., & Switzer, S. (2012) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2012.0100 · Cited by 5
Management of Type 2 Diabetes Mellitus
Marks, J. B. (2011) · Springer eBooks · doi:10.1007/978-1-4614-1028-7_8 · Cited by 4
Initiating a glucagon-like peptide-1 receptor agonist in the management of type 2 diabetes mellitus.
Gavin, J. R. (2012) · PubMed · Cited by 4
Tegegne, A. S. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s309925 · Cited by 4
Development of an unsupportive social interaction scale for patients with diabetes
Baron‐Epel, O., Heymann, A. D., Friedman, N. L., & Kaplan, G. (2015) · Patient Preference and Adherence · doi:10.2147/ppa.s83403 · Cited by 4
Incretin therapy for type 2 diabetes mellitus
Klonoff, D. C. (2010) · Advances in Therapy · doi:10.1007/s12325-010-0077-7 · Cited by 4
Rempel, C., Strohschoen, A. A. G., Hoerlle, J. L., Sartori, M. A. B., Busch, G. C., Périco, E., Pozzobon, A., Carreno, I., Bosco, S. M. D., Agostini, C., et al. (2010) · ConScientiae Saúde · doi:10.5585/conssaude.v9i1.2170 · Cited by 4
Economic evaluation of type 2 diabetes treatment with saxagliptin in Colombia
Elgart, J. F., González, L., Caporale, J., Valencia, J. E., & Gagliardino, J. J. (2012) · Medwave · doi:10.5867/medwave.2012.02.5306 · Cited by 3
Kellow, N. J., & Khalil, H. (2013) · International Journal of Pharmacy Practice · doi:10.1111/ijpp.12025 · Cited by 4
Management of Unmet Needs in Type 2 Diabetes Mellitus: The Role of Incretin Agents
Goldenberg, R. (2011) · Canadian Journal of Diabetes · doi:10.1016/s1499-2671(11)80008-0 · Cited by 3
Clinical Efficacy of Colesevelam in Type 2 Diabetes Mellitus
Brunetti, L., & Campbell, R. K. (2011) · Journal of Pharmacy Practice · doi:10.1177/0897190011406125 · Cited by 3
Kereiakes, D. J., & Neutel, J. M. (2011) · Drugs in R&D · doi:10.1007/bf03259726 · Cited by 3
Optimal treatment of the diabetic patient with multivessel disease
Bansilal, S., Farkouh, M. E., & Fuster, V. (2008) · Current Cardiology Reports · doi:10.1007/s11886-008-0045-x · Cited by 3
Fisher, M. (2009) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2009.02150.x · Cited by 3
Calle, M. C. (2013) · Journal of Advances in Medicine and Medical Research · doi:10.9734/bjmmr/2013/4248 · Cited by 3
Bringing Liraglutide to Market: A CER Case Study
Oderda, G. M., & Sifford-Wilson, S. M. (2012) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2012.18.s5-a.s12 · Cited by 3
Spending for Diabetes Drugs is Increasing in the United States
Klonoff, D. C. (2008) · Journal of Diabetes Science and Technology · doi:10.1177/193229680800200401 · Cited by 3
Kassahun, H., Genetu, A., Abuhay, T., & Tesfa, H. (2024) · BMJ Public Health · doi:10.1136/bmjph-2023-000828 · Cited by 2
Mehta, S. N., Goldfine, A. B., Abrahamson, M. J., McMullen, W., & Laffel, L. M. (2016) · Endocrine Practice · doi:10.4158/ep151080.or · Cited by 2
Demographics of Kidney Disease
Anderson, A. H., Berns, J. S., Bleicher, M. B., & Feldman, H. I. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4160-6193-9.10020-x · Cited by 2
Lin, Y., Bailey, J. E., Surbhi, S., Shuvo, S. A., Jackson, C., Chen, M., Price‐Haywood, E. G., Mann, J. R., Fort, D. G., Burton, J. H., et al. (2020) · JMIR Research Protocols · doi:10.2196/20788 · Cited by 2
Management of Type 2 Diabetes Mellitus
Dungan, K. M., & Buse, J. B. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00048-4 · Cited by 2
Descriptive Epidemiological Methods
Oleske, D. M. (2009) · Springer eBooks · doi:10.1007/978-1-4419-0164-4_3 · Cited by 2
Metadata
- Authors
- Ong, K. L., Cheung, B. M. Y., Wong, L. Y. F., Wat, N. M. S., Tan, K. C. B., & Lam, K. S. L.
- Affiliations
- University of Hong Kong (HK)
- Corresponding author
- Cheung, Bernard M.Y.
- Venue
- Annals of Epidemiology
- Publisher
- Elsevier BV
- Published
- 2008-03
- Volume
- 18
- Issue
- 3
- Pages
- 222-229
- ISSN
- 1047-2797 (ISSN-L)
- OpenAlex
- W2029084557
- Cited by
- 232
- References
- 35
- Citations by year
- 2025: 3 · 2024: 2 · 2023: 1 · 2022: 1 · 2021: 8 · 2020: 7 · 2019: 6 · 2018: 6 · 2017: 8 · 2016: 9 · 2015: 13 · 2014: 21 · 2013: 21 · 2012: 22
- FWCI
- 25.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of Epidemiology (publishedVersion)
- PubMed (publishedVersion)
- The HKU Scholars Hub (University of Hong Kong) (submittedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- diagnosed diabetes, diabetes prevalence, diabetes treatment, glycemic control, blood pressure control, cholesterol management, HbA1c, antidiabetic therapy, diabetes trends, obesity, sex differences, racial differences
- MeSH terms
- Adult, Aged, Diabetes Mellitus, Female, Humans, Male, Middle Aged, Nutrition Surveys, Regression Analysis, United States, Prevalence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review